These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2173157

  • 1. [Serum type III procollagen N-terminal peptide in patients with collagen diseases].
    Aoki A, Hagiwara E, Atsumi Y, Shirai A, Igarashi T, Narita M, Matsunaga K, Ishigatsubo Y, Tani K, Okubo T.
    Ryumachi; 1990 Apr; 30(2):81-4. PubMed ID: 2173157
    [Abstract] [Full Text] [Related]

  • 2. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
    Matsumoto S, Shindo J, Horiba M, Hara M, Inoue K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
    [Abstract] [Full Text] [Related]

  • 3. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
    Niitsu N, Umeda M.
    Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
    [Abstract] [Full Text] [Related]

  • 4. [Serum hyaluronic acid and aminoterminal procollagen III peptide in inflammatory and degenerative joint diseases].
    Seibel MJ, Raimann S, Seglias J, Lautenschläger J, Müller W.
    Z Rheumatol; 1988 Nov; 47(2):98-106. PubMed ID: 3388993
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, Delcambre B.
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH.
    Ital J Biochem; 2005 Mar; 54(3-4):248-57. PubMed ID: 16688934
    [Abstract] [Full Text] [Related]

  • 10. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen.
    Steinmann B, Superti-Furga A, Joller-Jemelka HI, Cetta G, Byers PH.
    Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989
    [Abstract] [Full Text] [Related]

  • 11. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
    Bolarin M.
    J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
    [Abstract] [Full Text] [Related]

  • 12. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
    Hørslev-Petersen K, Ammitzbøll T, Engström-Laurent A, Bentsen K, Junker P, Asboe-Hansen G, Lorenzen I.
    J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985
    [Abstract] [Full Text] [Related]

  • 13. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M, Acartürk E, Inal T, Attila G, Dönmez Y, Avkaroğullari M, Cayli M.
    Cardiovasc Pathol; 2007 Mar; 16(2):69-74. PubMed ID: 17317538
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Procollagen type-III aminoterminal peptide in serum and synovial fluid of dogs with hip dysplasia and coxarthrosis.
    Madsen JS, Jensen LT, Strøm H, Hørslev-Petersen K, Svalastoga E.
    Am J Vet Res; 1990 Oct; 51(10):1544-6. PubMed ID: 2240774
    [Abstract] [Full Text] [Related]

  • 16. [N-procollagen(III)peptide and lysosomal beta-galactosidase in progressive scleroderma and silicosis].
    Schulze E, Herrmann K, Haustein UF, Mehlhorn J, Böhme HJ.
    Dermatol Monatsschr; 1990 Oct; 176(11):687-93. PubMed ID: 2128055
    [Abstract] [Full Text] [Related]

  • 17. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 18. [Clinical usefulness of the measurement of type-II procollagen carboxypeptide (C-II propeptide, pColl-II-C) in synovial fluid as a marker of collagen metabolism in cartilage].
    Shinmei M, Nagaya I, Miyanaga Y, Iwata H, Yamamoto S, Torisu T, Fujii K, Fukubayashi T, Kondo M, Kurosaka M.
    Ryumachi; 1992 Oct 15; 32(5):453-60. PubMed ID: 1440081
    [Abstract] [Full Text] [Related]

  • 19. Prolyl hydroxylase and procollagen III peptide levels in the sera from patients with collagen diseases and psoriasis.
    Sasaki T, Nakajima H.
    J Dermatol; 1989 Jun 15; 16(3):207-11. PubMed ID: 2551942
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.